Epstein-Barr virus and the B cell: that's all it takes
- 31 May 1996
- journal article
- review article
- Published by Elsevier in Trends in Microbiology
- Vol. 4 (5), 204-208
- https://doi.org/10.1016/s0966-842x(96)90020-7
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Inhibition of antigen processing by the internal repeat region of the Epstein–Barr virus nuclear antigen-1Nature, 1995
- A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex.The Journal of Experimental Medicine, 1995
- Integral membrane protein 2 of Epstein—barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinasesImmunity, 1995
- The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor familyCell, 1995
- Epstein-Barr virus strategy in normal and neoplastic B cellsCell, 1994
- Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A.The Journal of Experimental Medicine, 1992
- CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.The Journal of Experimental Medicine, 1992
- Homology of Cytokine Synthesis Inhibitory Factor (IL-10) to the Epstein-Barr Virus Gene BCRFIScience, 1990
- Early events in Epstein-Barr virus infection provide a model for B cell activation.The Journal of Experimental Medicine, 1985
- In vitro analysis of the epstein‐barr virus: Host balance in long‐term renal allograft recipientsInternational Journal of Cancer, 1985